Bloodstream infection: An ounce of prevention is a ton of work

Infection Control and Hospital Epidemiology

Volumn 26, Issue 6, 2005, Pages 511-514

  Safdar, Nasia ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; EDETATE SODIUM; EDETIC ACID; HEPARIN; METICILLIN; VANCOMYCIN;

BACTEREMIA; BACTERIAL ENDOCARDITIS; BIOFILM; CANDIDA ALBICANS; CATHETER INFECTION; DEVICE INFECTION; EDITORIAL; ESCHERICHIA COLI; EVIDENCE BASED MEDICINE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEALTH CARE COST; HEALTH ECONOMICS; HEMODIALYSIS; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; KIDNEY FAILURE; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PHYSICIAN; PRACTICE GUIDELINE; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS EPIDERMIDIS;

ANTI-INFECTIVE AGENTS, LOCAL; BACTEREMIA; BIOFILMS; CATHETERIZATION, CENTRAL VENOUS; CATHETERIZATION, PERIPHERAL; CROSS INFECTION; EQUIPMENT CONTAMINATION; HUMANS; INFECTION CONTROL;

EID: 21244503158     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/502576     Document Type: Editorial

References (41)

1. Arnow PM, Quimosing EM, Beach M. Consequences of intravascular catheter sepsis. Clin Infect Dis 1993;16:778-784.
2. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs and attributable mortality. JAMA 1994;271:1598-1601.
3. Collignon PJ. Intravascular catheter associated sepsis: a common problem. The Australian Study on Intravascular Catheter Associated Sepsis. Med J Aust 1994;16:374-378.
4. Rello J, Ochagavia A, Sabanes E, et al. Evaluation of outcome of intravenous catheter-related infections in critically ill patients. Am J Respir Crit Care Med 2000;162:1027-1030.
5. Smith RL, Meixler SM, Simberkoff MS. Excess mortality in critically ill patients with nosocomial bloodstream infections. Chest 1991;100:164-167.
6. Percival SL, Kite P, Eastwood K, et al. Tetrasodium EDTA as a novel central venous catheter lock solution against biofilm. Infect Control Hosp Epidemiol 2005;26:515-519.
7. Bleyer AJ, Mason L, Russell G, Raad II, Sherertz RJ. A randomized, controlled trial of a new vascular catheter flush solution (minocycline-EDTA) in temporary hemodialysis access. Infect Control Hosp Epidemiol 2005;26:520-524.
8. Rubinson L, Wu AW, Haponik EF, Diette GB. Why is it that internists do not follow guidelines for preventing intravascular catheter infections? Infect Control Hosp Epidemiol 2005;26:525-533.
9. Engemann JJ, Friedman JY, Reed SD, et al. Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis. Infect Control and Hospital Epidemiol 2005;26:534-539.
10. Morgan J, Meltzer MI, Plikaytis BD, et al. Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance. Infect Control Hosp Epidemiol 2005;26:540-547.
11. Maki DG, Mermel LA. Infections due to infusion therapy. In: Bennet JV, Brachman PS, eds. Hospital Infections. Philadelphia: Lippincott-Raven; 1998:689-724.
12. Safdar N, Maki DG. The pathogenesis of catheter-related blood-stream infection with noncuffed short-term central venous catheters. Intensive Care Med 2004;30:62-67.
13. Crnich CJ, Maki DG. The promise of novel technology for the prevention of intravascular device-related bloodstream infection: II. Long-term devices. Clin Infect Dis 2002;34:1362-1368.
14. Sitges-Serra A, Puig P, Linares J, et al. Hub colonization as the initial step in an outbreak of catheter-related sepsis due to coagulase negative staphylococci during parenteral nutrition. JPEN J Parenter Enteral Nutr 1984;8:668-672.
15. Raad I, Costerton W, Sabharwal U, Sacilowski M, Anaissie E, Bodey GP. Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement. J Infect Dis 1993;168:400-407.
16. Garland JS, Alex CP, Mueller CD, et al. A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates. Pediatrics 2001;107:1431-1436.
17. Bouza E, Burillo A, Munoz P. Catheter-related infections: diagnosis and intravascular treatment. J Chemother 2001;13:224-233.
18. Carratala J. Role of antibiotic prophylaxis for the prevention of intravascular catheter-related infection. Clin Microbiol Infect 2001;7(suppl 4):83-90.
19. Capdevila JA. Catheter-related infection: an update on diagnosis, treatment, and prevention. Int J Infect Dis 1998;2:230-236.
20. Safdar N, Maki D. The use of vancomycin lock and flush solutions for the prevention of catheter-related bloodstream infection. Presented at the 15th Annual Meeting of the Society for Healthcare Epidemiology of America; April 17-20, 2004; Philadelphia, PA.
21. Jurewitsch B, Lee T, Park J, Jeejeebhoy K. Taurolidine 2% as an antimicrobial lock solution for prevention of recurrent catheter-related bloodstream infections. JPEN J Parenter Enteral Nutr 1998;22:242-244.
22. Dogra GK, Herson H, Hutchison B, et al. Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: a randomized controlled study. J Am Soc Nephrol 2002;13:2133-2139.
23. Chatzinikolaou I, Zipf TF, Hanna H, et al. Minocycline- ethylenediaminetetraacetate lock solution for the prevention of implantable port infections in children with cancer. Clin Infect Dis 2003;36:116-119.
24. Maki DG, Crnich CJ, Safdar N. Ethanol lock solution for prevention of recurrent IVDR BSI. Presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy; September 14-17, 2003; Chicago, IL.
25. Kite P, Eastwood K, Sugden S, Percival SL. Use of in vivo-generated biofilms from hemodialysis catheters to test the efficacy of a novel antimicrobial catheter lock for biofilm eradication in vitro. J Clin Microbiol 2004;42:3073-3076.
26. Chaiyakunapruk N, Veenstra DL, Lipsky BA, Saint S. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. Ann Intern Med 2002;136:792-801.
27. Raad II, Hohn DC, Gilbreath BJ, et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol 1994;15:231-238.
28. Berenholtz SM, Pronovost PJ. Barriers to translating evidence into practice. Curr Opin Crit Care 2003;9:321-325.
29. Maue SK, Segal R, Kimberlin CL, Lipowski EE. Predicting physician guideline compliance: an assessment of motivators and perceived barriers. American Journal of Managed Care 2004;10:383-391.
30. Cabana MD, Rand CS, Powe NR, et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999;282:1458-1465.
31. Pathman DE, Konrad TR, Freed GL, Freeman VA, Koch GG. The awareness-to-adherence model of the steps to clinical guideline compliance: the case of pediatric vaccine recommendations. Med Care 1996;34:873-889.
32. Davis DA, Thomson MA, Oxman AD, Haynes RB. Changing physician performance: a systematic review of the effect of continuing medical education strategies. JAMA 1995;274:700-705.
33. O'Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. MMWR 2002;51(RR-10):1-29.
34. Berenholtz SM, Pronovost PJ, Lipsett PA, et al. Eliminating catheter-related bloodstream infections in the intensive care unit. Crit Care Med 2004;32:2014-2020.
35. Rosenthal VD, Guzman S, Pezzotto SM, Crnich CJ. Effect of an infection control program using education and performance feedback on rates of intravascular device-associated bloodstream infections in intensive care units in Argentina. Am J Infect Control 2003;31:405-409.
36. Dopirak M, Hill C, Oleksiw M, et al. Surveillance of hemodialysis- associated primary bloodstream infections: the experience of ten hospital-based centers. Infect Control Hosp Epidemiol 2002;23:721-724.
37. Sexton DJ. Vascular access infections in patients undergoing dialysis with special emphasis on the role and treatment of Staphylococcus aureus. Infect Dis Clin North Am 2001;15:731-742, vii.
38. Tokars JI. Bloodstream infections in hemodialysis patients: getting some deserved attention. Infect Control Hosp Epidemiol 2002;23:713-715.
39. Reed SD, Friedman JY, Engemann JJ, et al. Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 2005;26:175-183.
40. Tokars JI, Frank M, Alter MJ, Arduino MJ. National surveillance of dialysis-associated diseases in the United States, 2000. Semin Dial 2002;15:162-171.
41. Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in medical intensive care units in the United States. Crit Care Med 1999;27:887-892.